Skip to content
10-K

Annual Report

Zosano Pharma Corp

0001587221-22-000022

← back to feed
Filed
Mar 17, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2021 · Dec 31, 2021 112.06M sh
Shares Diluted FY 2021 · Dec 31, 2020 67.91M sh
Capex FY 2021 · Dec 31, 2021 $5.42M
Capex FY 2021 · Dec 31, 2020 $8.49M
Operating Cash Flow FY 2021 · Dec 31, 2021 −$27.59M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$31.72M
Long Term Debt FY 2021 · Dec 31, 2021 $0
Long Term Debt FY 2021 · Dec 31, 2020 $812K
Short Term Debt FY 2021 · Dec 31, 2021 $0
Short Term Debt FY 2021 · Dec 31, 2020 $809K
Cash And Equivalents FY 2021 · Dec 31, 2021 $11.04M
Cash And Equivalents FY 2021 · Dec 31, 2020 $35.26M
Stockholders Equity FY 2021 · Dec 31, 2021 $32.98M
Stockholders Equity FY 2021 · Dec 31, 2020 $47.52M
Stockholders Equity FY 2021 · Dec 31, 2019 $9.39M
Current Liabilities FY 2021 · Dec 31, 2021 $11.13M
Current Liabilities FY 2021 · Dec 31, 2020 $14.51M
Total Liabilities FY 2021 · Dec 31, 2021 $15.42M
Total Liabilities FY 2021 · Dec 31, 2020 $24.5M
Current Assets FY 2021 · Dec 31, 2021 $11.61M
Current Assets FY 2021 · Dec 31, 2020 $35.72M
Total Assets FY 2021 · Dec 31, 2021 $48.39M
Total Assets FY 2021 · Dec 31, 2020 $72.01M
Eps Diluted FY 2021 · Dec 31, 2021 −$0.27
Eps Diluted FY 2021 · Dec 31, 2020 −$0.49
Eps Basic FY 2021 · Dec 31, 2021 −$0.27
Eps Basic FY 2021 · Dec 31, 2020 −$0.49
Sga Expense FY 2021 · Dec 31, 2021 $10.55M
Sga Expense FY 2021 · Dec 31, 2020 $11.19M
Rd Expense FY 2021 · Dec 31, 2021 $20.97M
Rd Expense FY 2021 · Dec 31, 2020 $21.62M
Net Income FY 2021 · Dec 31, 2021 −$29.93M
Net Income FY 2021 · Dec 31, 2020 −$33.37M
Operating Income FY 2021 · Dec 31, 2021 −$31.53M
Operating Income FY 2021 · Dec 31, 2020 −$32.76M
Cost Of Revenue FY 2021 · Dec 31, 2021 $796K
Cost Of Revenue FY 2021 · Dec 31, 2020 $171K
Revenue FY 2021 · Dec 31, 2021 $785K
Revenue FY 2021 · Dec 31, 2020 $224K